Skip to navigation menu Skip to content
Clinical Trial Search block Test

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy

Agamree_Registry_(DMD-001)

  • Phase: Registry
  • Clinicaltrials.gov ID: NA

What is the goal of the study?

The primary objective is to collect additional information on the safety of long term treatment with AGAMREE® in male patients aged 2 years and older with DMD

Who can participate in the study?

Everyone

Study Team: